AN ALERT SYSTEM FOR COMPARING SOME DRUG CLASS IN TWO DIFFERENT HEALTH CARE SYSTENS FROM THE COST SENSITIVTY ANALYSIS OF PHYSICIANS
THE CASE OF BETABLOCKERS IN HEALTH SYSTEMS A AND B
In system A: 12 % of GNP is spent on health care and physicians are paid on a fee for service basis.
Y measures the prescribing intention shift in the metric under development (from scaled standardized measures). The 16% cost sensitive physicians of 100 surveyed physicians in this system A intent to prescribe more diuretics (measured in the current metrics used for the cost sensitivity index (which represent the largest drug class in market share (23%) according to IMS data at the time of the study in that system). The cost sensitivity analysis is restricted in this study to cues describing cost information related to patient charges such as patient affordability, patient demand for cheaper treatment, co payment for comedications, severity of the condition or presence of comorbidities/risk factors.
In system B: 7 % of GNP is spent on health care , physicians are accountable for prescribing budgets and are gatekeepers.
Source : Endep/Biomed book, published by IOS publisher, 2003